NanobacTX

NanoBioTech
What is NanobacTX?

NanobacTX is a patented non-prescription all-oral nanobiotic compound shown in published cardiology studies to reverse/regress atherosclerosis, calcified coronary artery plaque, improve lipid profiles and eliminate heart disease symptoms like angina. NanobacTX is the only product ever shown to dissolve, eradicate and regress calcified arterial plaque and calcification deposits in blood vessels, organs and tissues. Our published cardiology studies show that NanobacTX decreases heart disease symptoms, angina and increases exercise ability. NanobacTX alleviates inflammation, coronary artery calcification and improves coronary artery blood flow and vascular flexibility. NanobacTX decreases calcified arterial and coronary artery plaque volume after a core program of 6-12 months of full nightly treatment of 8 capsules/night. A maintenance program dosage of 1-2 capsules/night is then required to prevent regression.  Reimagine Aging without heart disease or arteriosclerosis and feeling wonderful! 




An Independent Summary of Our Scientific Research & Clinical Studies: Anton Kutikin, PhD in The International Journal of NanoMedicine "The Role of CNPs in Biology & Medicine" www.ncbi.nlm.nih.gov/pmc/articles/PMC3266001

(Please note that for publishing purposes, our Nanobiotics were referred-to as comET for generic purposes and not our actual tradenames of NanobacTX & Urobac. Scientific publications allow only the use of generic names and not trademark names.)


More published Scientific Research and Clinical Studies:

Altundag K, Altundag O, Akyurek S, Atik MA. Possible association between nanobacteria and malignant microcalcifications in breast cancer.Breast J.2006 May-Jun; 12(3):287.www.ncbi.nlm.nih.gov

Puskas, L. G., L. Tiszlavicz, Zs Razga, L. Torday, T. Krenacs, J. G Papp. Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biologica Hungarica56 (3-4): 233-245.www.ncbi.nlm.nih.gov

1.Hudelist G., C. F. Singer, E. Kubista, M. Manavi, R. Mueller, K. Pischinger, K. Czerwenka. Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence of pathogenetic role in intratumoral biomineralization.Histopathology.45, 633-637.Click here to view study

2.Jelic T. M., A. M. Malas, S. S. Groves, B. Jin, P. F. Mellen, G. Osborne, R. Roque, J. G. Rosencrance, and H. H. Chang. Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure.South Med J.Feb; 97 (2): 194- 198.Click here to view study

3.Lieske J. C., V. Kumar, G. Farell-Baril, S. Yu, J. E. Charlesworth, E. Rzewusk-Lech, P. LaBreche, S. R. Severson, and V. M. Miller. Mayo Clinic.Detection and propagation of calcified nanostructures from human aneurysm.J Am Coll Cardiol Abstracts Book.1059-13: 13A.Click here to view study

4.Maniscalco, B.S., Mezo, G.S. Calcification in coronary artery disease can be reversed.Intl Journal of Pathophysiology.11(2): 95-101.Click here to view study

Miller, V. M., G. Rodgers, J. A. Charlesworth, B. Kirkland, S. R. Severson, T. E. Rasmussen, M. Yagubyan, J. C. Rodgers, F. R Cockerill, III, R. L. Folk, V. Kumar, G. Farell-Baril, J. C. Lieske. Mayo Clinic.Evidence of nanobacterial-like structures in human calcified arteries and cardiac valves.Am J Physiol Heart Circ Physiol.287 (3): H1115-24.www.ncbi.nlm.nih.gov

5.Ciftcioglu, N., D. S. McKay, E.O. Kajander.Association between nanobacteria and periodontal disease.Circulation.108:e58-9.Click here to view study

6.Kajander, E O.Nanobacteria do exist and actively participate in the calcification of arterial plaque.Townsend Letter 234:80-82.Click here to view study

7.Sedivy, R., and W. B. Battistutti. Nanobacteria promote crystallization of psammoma bodies in ovarian cancer.APMIS III.951-4.Click here to view study

8.Sommer, A. P., U. Oron, A. M. Pretorius, D. S. McKay, N. Ciftcioglu, A. R. Mester, E. O. Kajander and H. T. Whelan, NASA-JSC. Light-modulated replication of nanobacteria and heart disease.J. Clin. Laser Med. Surg.21 (4): 231-235.Click here to view study

9.Ciftcioglu, N., M. A. Miller-Hjelle. J. T. Hjelle and E. O. Kajander.Inhibition of Nanobacteria as measured by a modified microdilution method.Antimicrob Agents Chemother.46: 2077-2086.Click here to view study

10.Kajander, E. O., K. Aho and V. Segal. Apatite biofilm forming agent: nanobacteria as a model system for biomineralization and biological standard for noa, a preliminary study.Proceedings of the 2nd International Conference on Near-Field Optical analysis. Houston, Texas.Click here to view study

11.Rasmussen, T. E., B. L. Kirkland, J. Charlesworth, et al.Electron microscope and immunological evidence of nanobacteria in calcified carotid arteries, aortic aneurysms and cardiac valves.J Am Coll Cardiol Abstracts Book.1009-79: 206A.Click here to view study

Lopez-Brea M., R. Selgas. Nanobacteria as a cause of renal diseases and vascular calcifying pathology in renal patients (endovascular lithiasis).Enferm Infec. Microbiol. Cli. (Spanish).18(10):491-492.www.ncbi.nlm.nih.gov

12.Ciftcioglu, N., V. Ciftcioglu, H. Vali, E. Turcott, E. O. Kajander. Sedimentary rocks in our mouth: dental pulp stones made by nanobacteria. Proc. SPIE.3441: 130-135.Click here to view study


Studies specific to DERMATOLOGY:

1.Harvima, Rauno MD. Association of Nanobacteria with Dermatologic Diseases. International Nanobacteria Symposium. Kuopio, Finland; 3/8/2001. Click here to view study

Morgan, M. B. Nanobacteria and calcinosis cutis. J. Cutan Pathol.29(3):173-175.www.ncbi.nlm.nih.gov


Studies specific to Pathological Calcification & CNPs (aka Nanobacteria):

2.Kajander EO. Nanobacteria - propagating calcifying nanoparticles. Lett Appl Microbiol. 2006 Jun; 42(6):549-52. Click here to view study

Altundag K, Altundag O, Akyurek S, Atik MA. Association between nanobacteria and malignant microcalcifications in breast cancer. Breast J.2006 May-Jun; 12(3):287. www.ncbi.nlm.nih.gov

3. Tsurumoto T., T. Matsumoto, A. Yonekura, and H. Shindo. 2006. Nanobacteria in Human Arthritic Synovial Fluids. Journal of Proteome Research. ASAP Article 10.1021/pr050450w S1535-3893(05)00450-1 [Web Release April 8, 2006] American Chemical Societypubs.acs.org Click here to view study

Ciftioglu, N. Nanobacteria-Discovery of a new form of life. Horizons 2006 March 31: 7-8. www.aiaa-houston.org/newsletter

4.Sommer, A. P., N. C. Wichramasinghe. 2005. Functions and Possible Provenance of Primordial Proteins-Part II: Microorganism Aggregation in Clouds Triggered by Climate Change. Journal of Proteome Research. 4: 180-184. Click here to view study

Sommer, A. P. 2005. Primordial proteins and HIV-Part II. Journal of Proteome Research. 4(3): 1022 - 1024. www.ncbi.nlm.nih.gov

Sommer, A. P., A. E. Pavlath. 2005. Primordial proteins and HIV. Journal of Proteome Research. 4(2): 633-636. www.ncbi.nlm.nih.gov

5.Hudelist G., C. F. Singer, E. Kubista, M. Manavi, R. Mueller, K. Pischinger, K. Czerwenka. 2004. Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence of pathogenetic role in intratumoral biomineralization. Histopathology. 45, 633-637. Click here to view study

Pretorius, A. M., A. P. Sommer, K. M. Aho, E. O. Kajander. 2004. HIV and nanobacteria. HIV Med. 5(6):391-393. www.ncbi.nlm.nih.gov

6.Sommer, A. P., A. M. Pretorius, E. O. Kajander, and U. Oron. 2004. Biomineralization induced by stressed nanobacteria. Crystal Growth & Design. 4 (1): 45-46. Click here to view study

7.Sommer, A. P., N. C. Wichramasinghe. 2005. Functions and Possible Provenance of Primordial Proteins-Part II: Microorganism Aggregation in Clouds Triggered by Climate Change. Journal of Proteome Research. 4: 180-184. Click here to view study

8.Wang, X.J., Liu, W., Yang, Z.L., Wei, H., Wen, Y., Li, Y.G. 2004. The detection of nanobacteria infection in serum of healthy Chinese people. Zhonghua Liu Xing Bing Xue Za Zhi. 25(6): 494-4. Click here to view study

9.Wilk, I., G. Martirosian, K. Z. Mikrobiologii, S. A. Medycznei, Khatowice. 2004. Nanobacteria microbiological characteristic. Postepy Hig Med Dosw (online), 2004; 58: 60-64. Click here to view study

10.Aho K, Kajander EO. 2003. Detection of novel nanoorganisms .J Clin Microbiol. 41(7): 3460-3461. Click here to view study

Barr S. C., R. A. Linke, D. Janssen, C. L. Guard, M. C. Smith, C. S. Daugherty, J. M. Scarlett. 2003. Detection of biofilms formation and nanobacteria under long-term cell culture conditions in serum samples of cattle, goats, cats and dogs. Am J Vet Res. 64(2):176-182.

11.Miller-Hjelle, M. A., J. T. Hjelle, N. Ciftcioglu and E. O. Kajander. 2003. Nanobacteria: methods for growth and identification of this recently discovered calciferous agent. Rapid Analytical Microbiology. The chemistry and physics of microbial identification. Ed. . Olson. PDA, Bethesda, MD, USA. 297-312. Click here to view study

12.Miller-Hjelle, M. A., S. L. Stobbs, I. R. Poxton, J. T. Hjelle. 2003. Nanobacteria antigen and antibody titres in USA controls compared to UK controls and kidney disease patients. 13th European Congress of Clinical Microbiology & Infectious Diseases. P1663. Click here to view study

13.Sedivy, R., and W. B. Battistutti. 2003. Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS III. 951-4. Click here to view study

15. Sommer, A. P., D. S. McKay, N. Ciftcioglu, U. Oron, A. R. Mester, and E. O. Kajander. 2003. Living nanovesicles-chemical and physical survival strategies of primordial biosystems. Perspectives, J. Proteome Res. 2:441-443. Click here to view study

16.Sommer, A. P., U. Oron, A. M. Pretorius, D. S. McKay, N. Ciftcioglu, A. R. Mester, E. O. Kajander and H. T. Whelan. 2003. A preliminary investigation into light-modulated replication of nanobacteria and heart disease. J. Clin. Laser Med. Surg. 21 (4): 231-235. Click here to view study

17.Ciftcioglu, N., M. A. Miller-Hjelle. J. T. Hjelle and E. O. Kajander. 2002. Inhibition of nanobacteria as measured by a modified microdilution method. Antimicrob Agents Chemother. 46: 2077-2086. Click here to view study

18.Kajander, E. O., K. Aho and V. Segal. October, 2002. Apatite biofilm forming agent: nanobacteria as a model system for biomineralization and biological standard for noa, a preliminary study. Proceedings of the 2nd International Conference on Near-Field Optical analysis: Photodynamic Therapy & Photobiology Effects. Houston, Texas. Click here to view study

Sommer A. P., H. I. Hassinen, E. O. Kajander. 2002. Light-induced replication of nanobacteria: a preliminary report. J Clin Laser Med Surg.20(5):241-244.www.ncbi.nlm.nih.gov

19.Sommer, A. P., U. Oron, E. O. Kajander and A. R. Mester. 2002. Stressed cells survive better with light. J. Proteome Res.1:475. Click here to view study

20.Breitschwerdt, E. B., Sushama, S., Cannedy, A., Hancock, S. I., Bradley. J. M. 2001. Infection with Bartonella weissii and detection of nanobacterium antigens in a North Carolina beef herd Journal of Clinical Microbiology. 879-882. Click here to view study

21.Vali, H., M. D. McKee, N. Ciftcioglu, S. K. Sears, F. L. Plows, E. Chelvet, P. Ghiasi, E. O. Kajander and R. N. Zare. 2001. Nanoforms: a new type of protein-associated mineralization. Geochim.Cosmochim. Acta. 65:63-74. Click here to view study

22.Ciftcioglu, N. and E. O. Kajander. 2000. Nanobacterial growth factors for nanobacteria Proc. SPIE. 3755: 113-119. Click here to view study

23.Kajander, E. O. and N. Ciftcioglu. 2000. Nanobacteria as extremophiles Proc. SPIE. 3755: 106-112. Click here to view study

Vainshtein M. B., E. B. Kudriashova. 2000. About nanobacteria. Mikrobiologiia (Russian). 69(2):163-174. www.ncbi.nlm.nih.gov

Abbott, A. 1999. Battle lines drawn between nanobacteria researchers. 1999. Nature. 401 (6749):105. www.ncbi.nlm.nih.gov

24.Ciftcioglu, N. 1999. Microbial presence versus pathogenicity. Pleomorphic microbes in health and disease. Proceedings of the first annual symposium held June 18-19. Edited by: Gitte S. Jensen Ph.D. Holger N.I.S. Inc.; 49-53. Click here to view study

25.Kajander, E. O., M. Bjorklund, N. Ciftcioglu. 1999. Nanobacteria and man. Enigmatic Microorganisms and Life in Extreme Environments. Eds.J. Seckbach, Kluwer (the Netherlands). 195-204. Click here to view study

26.Kajander, E. O. 1999. Nanobacteria in health and disease. Pleomorphic microbes in health and disease. Proceedings of the first annual symposium held June 18-19, 1999. Edited by: Gitte S. Jensen Ph.D. Holger N.I.S. Inc. Hudson, Quebec; 43-48. Click here to view study

27.Kajander, E. O., T. Heinonen, I. Kuronen, K. Luoto and N. Ciftcioglu. 1999. A new problem for sterile filtration; nanobacteria. In Proceedings, WorldPharm. 99, October 26-28, 1999, Philadelphia. Advanstar Communications, Cleveland, OH. Pp. 243-252. Click here to view study

28.Kajander, E. O., T. Heinonen, I. Kuronen, K. Luoto, and N. Ciftcioglu. Nanobacteria, mycoplasma and bacterial l-forms; problems for sterile filtration. 30th R3. Nordic Contamination Control Symposium.Helsinki, Finland. Click here to view study

Southam, G., R. Donald. 1999. A structural comparison of bacterial microfossils vs. nanobacteria and nanofossils. Earth-Science Reviews.48 (4): 251-264.

29.Wainwright, M. 1999. Nanobacteria and associated elementary bodies in human disease and cancer. Microbiology. 145: 2623-2624. Click here to view study

30.Bjorklund, M., N. Ciftcioglu, E. O. Kajander. 1998. Extraordinary survival of nanobacteria under extreme conditions. Proc. SPIE. 3441: 123-129. Click here to view study

31.Carson, D. A. 1998. An infectious origin of extraskeletal calcification. PNAS.95: 7846-7847. Click here to view study

32.Ciftcioglu, N., E. O. Kajander. 1998. Interaction of nanobacteria with cultured mammalian cells. Pathophysiology. 4: 259-270. Click here to view study

33.Ciftcioglu, N., M. Bjorklund, E. O. Kajander. 1998. Stone formation and calcification by nanobacteria in human body. Proc. SPIE.3441: 105-111. Click here to view study

34.Ciftcioglu, N., V. Ciftcioglu, H. Vali, E. Turcott, E. O. Kajander. 1998. Sedimentary rocks in our mouth: dental pulp stones made by nanobacteria.Proc. SPIE. 3441: 130-135. Click here to view study

35.Kajander, E. O., M. Bjorklund and N. Ciftcioglu. 1998. Suggestions from observations on nanobacteria isolated from blood. Size limits of very small microorganisms: proceedings of a workshop, steering group on astrobiology of the Ciftcioglu, N., M. Bjorklund, K. Kuorikoski, K. Click here to view study

Bergstrom and EO. Kajander. 1999. Nanobacteria: An infectious cause for kidney stone formation. Kidney International. 56:1893-1898. studies board National Research Council; Washington, D.C. October 22-23. www.ncbi.nlm.nih.gov

36.Kajander, E. O., N. Ciftcioglu, M. Bjorklund. 1998. Mineralization by nanobacteria Proc. SPIE. 3441: 86-94. Click here to view study

37.Kajander, E. O., N. Ciftcioglu. 1998. Nanobacteria: An alternative mechanism for pathogenic intra- and extracellular calcification and stone formation Proc. Natl. Acad. Sci. USA 95: 8274-8279. Click here to view study

38.Akerman, K. K., J. T. Kuikka, N. Ciftcioglu, J. Parkkinen, K. A. Bergstrom, I. Kuronen, and E. O. Kajander. 1997. Radiolabeling and in vivo distribution of nanobacteria in rabbit. Proc. SPIE. 3111: 436-442. Click here to view study

39.Ciftcioglu, N., A. Pelttari, E. O. Kajander. 1997. Extraordinary growth phases of nanobacteria isolated from mammalian blood. Proc. SPIE. 3111: 429-435. Click here to view study

40.Cifcioglu, N., I. Kuronen, K. Akerman, E. Hiltunen, J. Laukkanen, E.O. Kajander. 1997. E. F. Brown, D. Burton, P. Doherty, J. Makalanos, E. Norrby. A new potential threat in antigen and antibody products: nanobacteria. Cold spring harbor laboratory. Vaccines 97. 99-103. Click here to view study

41.Kajander, E. O., I. Kuronen; K. Akerman, A. Pelttari, N. Ciftcioglu. 1997. Nanobacteria from blood, the smallest culturable autonomously replicating agent on earth. Proc. SPIE. 3111: 420-428. Click here to view study

42.Kajander, E. O., E. Tahvanainen, I. Kuronen, N. Ciftcioglu. 1994. Comparison of staphylococci and novel bacteria-like particles from blood. Zbl. Bakt. (Suppl.) 26: 147-149. Click here to view study

43.Akerman, K. K., I. Kuronen, and E. O. Kajander. 1993. Scanning electron microscopy of nanobacteria-novel biofilm producing organisms in blood. Scanning. 15 (Suppl.) 3:90-91. Click here to view study